Global Perfluorocarbon-based Ultrasound Contrast Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Perfluorocarbon-based Ultrasound Contrast Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 28 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.

According to our (Global Info Research) latest study, the global Perfluorocarbon-based Ultrasound Contrast Agents market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Perfluorocarbon-based Ultrasound Contrast Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perfluorocarbon-based Ultrasound Contrast Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perfluorocarbon-based Ultrasound Contrast Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, Qi-hui Biopharmaceutical, Feiruida Medical, SUNΛ Med-Engineering, Lizhuo Pharmaceutical, Fuman Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Perfluorocarbon-based Ultrasound Contrast Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Sulfur Hexafluoride
Perfluoropropane
Perfluorobutane
Others

Market segment by Application
Liver Ultrasonography
Angiographic Ultrasonography
Cardiac Ultrasonography
Others

Major players covered
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perfluorocarbon-based Ultrasound Contrast Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, with price, sales quantity, revenue, and global market share of Perfluorocarbon-based Ultrasound Contrast Agents from 2019 to 2024.
Chapter 3, the Perfluorocarbon-based Ultrasound Contrast Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perfluorocarbon-based Ultrasound Contrast Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Perfluorocarbon-based Ultrasound Contrast Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perfluorocarbon-based Ultrasound Contrast Agents.
Chapter 14 and 15, to describe Perfluorocarbon-based Ultrasound Contrast Agents sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Sulfur Hexafluoride
1.3.3 Perfluoropropane
1.3.4 Perfluorobutane
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Liver Ultrasonography
1.4.3 Angiographic Ultrasonography
1.4.4 Cardiac Ultrasonography
1.4.5 Others
1.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size & Forecast
1.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (2019-2030)
1.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Bracco
2.1.1 Bracco Details
2.1.2 Bracco Major Business
2.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bracco Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Lantheus Medical Imaging
2.3.1 Lantheus Medical Imaging Details
2.3.2 Lantheus Medical Imaging Major Business
2.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.3.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Lantheus Medical Imaging Recent Developments/Updates
2.4 ImaRx Therapeutics
2.4.1 ImaRx Therapeutics Details
2.4.2 ImaRx Therapeutics Major Business
2.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.4.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ImaRx Therapeutics Recent Developments/Updates
2.5 Microvascular Therapeutics
2.5.1 Microvascular Therapeutics Details
2.5.2 Microvascular Therapeutics Major Business
2.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Microvascular Therapeutics Recent Developments/Updates
2.6 Qi-hui Biopharmaceutical
2.6.1 Qi-hui Biopharmaceutical Details
2.6.2 Qi-hui Biopharmaceutical Major Business
2.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.6.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qi-hui Biopharmaceutical Recent Developments/Updates
2.7 Feiruida Medical
2.7.1 Feiruida Medical Details
2.7.2 Feiruida Medical Major Business
2.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.7.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Feiruida Medical Recent Developments/Updates
2.8 SUNΛ Med-Engineering
2.8.1 SUNΛ Med-Engineering Details
2.8.2 SUNΛ Med-Engineering Major Business
2.8.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.8.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 SUNΛ Med-Engineering Recent Developments/Updates
2.9 Lizhuo Pharmaceutical
2.9.1 Lizhuo Pharmaceutical Details
2.9.2 Lizhuo Pharmaceutical Major Business
2.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.9.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lizhuo Pharmaceutical Recent Developments/Updates
2.10 Fuman Group
2.10.1 Fuman Group Details
2.10.2 Fuman Group Major Business
2.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.10.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fuman Group Recent Developments/Updates

3 Competitive Environment: Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Manufacturer (2019-2024)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturer (2019-2024)
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Market Share in 2023
3.4.3 Top 6 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Market Share in 2023
3.5 Perfluorocarbon-based Ultrasound Contrast Agents Market: Overall Company Footprint Analysis
3.5.1 Perfluorocarbon-based Ultrasound Contrast Agents Market: Region Footprint
3.5.2 Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Type Footprint
3.5.3 Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2030)
4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2030)
4.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2019-2030)
4.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.4 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.5 South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.6 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
6.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2030)

7 North America
7.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
7.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
7.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
7.3.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
7.3.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
8.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
8.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
8.3.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
8.3.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
9.3.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
10.2 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
10.3 South America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
10.3.1 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
10.3.2 South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
11.3.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
12.2 Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
12.3 Perfluorocarbon-based Ultrasound Contrast Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Perfluorocarbon-based Ultrasound Contrast Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Perfluorocarbon-based Ultrasound Contrast Agents
13.3 Perfluorocarbon-based Ultrasound Contrast Agents Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Perfluorocarbon-based Ultrasound Contrast Agents Typical Distributors
14.3 Perfluorocarbon-based Ultrasound Contrast Agents Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bracco Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Major Business
Table 5. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 6. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bracco Recent Developments/Updates
Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. GE Healthcare Major Business
Table 10. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 11. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GE Healthcare Recent Developments/Updates
Table 13. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 14. Lantheus Medical Imaging Major Business
Table 15. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 16. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Lantheus Medical Imaging Recent Developments/Updates
Table 18. ImaRx Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. ImaRx Therapeutics Major Business
Table 20. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 21. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ImaRx Therapeutics Recent Developments/Updates
Table 23. Microvascular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Microvascular Therapeutics Major Business
Table 25. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 26. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Microvascular Therapeutics Recent Developments/Updates
Table 28. Qi-hui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Qi-hui Biopharmaceutical Major Business
Table 30. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 31. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Qi-hui Biopharmaceutical Recent Developments/Updates
Table 33. Feiruida Medical Basic Information, Manufacturing Base and Competitors
Table 34. Feiruida Medical Major Business
Table 35. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 36. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Feiruida Medical Recent Developments/Updates
Table 38. SUNΛ Med-Engineering Basic Information, Manufacturing Base and Competitors
Table 39. SUNΛ Med-Engineering Major Business
Table 40. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 41. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. SUNΛ Med-Engineering Recent Developments/Updates
Table 43. Lizhuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Lizhuo Pharmaceutical Major Business
Table 45. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 46. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Lizhuo Pharmaceutical Recent Developments/Updates
Table 48. Fuman Group Basic Information, Manufacturing Base and Competitors
Table 49. Fuman Group Major Business
Table 50. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 51. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Fuman Group Recent Developments/Updates
Table 53. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Perfluorocarbon-based Ultrasound Contrast Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 57. Head Office and Perfluorocarbon-based Ultrasound Contrast Agents Production Site of Key Manufacturer
Table 58. Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Type Footprint
Table 59. Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Application Footprint
Table 60. Perfluorocarbon-based Ultrasound Contrast Agents New Market Entrants and Barriers to Market Entry
Table 61. Perfluorocarbon-based Ultrasound Contrast Agents Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 63. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2024) & (Units)
Table 64. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2025-2030) & (Units)
Table 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 67. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2019-2024) & (US$/Unit)
Table 68. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2025-2030) & (US$/Unit)
Table 69. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 70. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 71. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2024) & (US$/Unit)
Table 74. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2025-2030) & (US$/Unit)
Table 75. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 76. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 77. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2024) & (US$/Unit)
Table 80. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2025-2030) & (US$/Unit)
Table 81. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 82. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 83. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 84. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 85. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 86. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 87. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 88. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 90. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 91. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 92. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 93. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 94. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 95. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 96. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 98. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 99. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 100. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 101. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2024) & (Units)
Table 102. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2025-2030) & (Units)
Table 103. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 105. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 106. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 107. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 108. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 109. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 110. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 111. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 114. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 115. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 116. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 117. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 118. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 119. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Perfluorocarbon-based Ultrasound Contrast Agents Raw Material
Table 122. Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents Raw Materials
Table 123. Perfluorocarbon-based Ultrasound Contrast Agents Typical Distributors
Table 124. Perfluorocarbon-based Ultrasound Contrast Agents Typical Customers


List of Figures
Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Picture
Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type in 2023
Figure 4. Sulfur Hexafluoride Examples
Figure 5. Perfluoropropane Examples
Figure 6. Perfluorobutane Examples
Figure 7. Others Examples
Figure 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application in 2023
Figure 10. Liver Ultrasonography Examples
Figure 11. Angiographic Ultrasonography Examples
Figure 12. Cardiac Ultrasonography Examples
Figure 13. Others Examples
Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (2019-2030) & (Units)
Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (2019-2030) & (US$/Unit)
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 21. Top 3 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer (Revenue) Market Share in 2023
Figure 22. Top 6 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer (Revenue) Market Share in 2023
Figure 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2019-2030)
Figure 35. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 48. France Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Region (2019-2030)
Figure 56. China Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 57. Japan Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 58. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 59. India Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 60. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 61. Australia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 62. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 67. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 71. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 72. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 73. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 75. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 76. Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
Figure 77. Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
Figure 78. Perfluorocarbon-based Ultrasound Contrast Agents Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents in 2023
Figure 81. Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 82. Perfluorocarbon-based Ultrasound Contrast Agents Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group
shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Perfluorocarbon-based Ultrasound Contrast Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Global Perfluorocarbon-based Ultrasound Contrast Agents Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 92

Published Date: 28 Aug 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Perfluorocarbon-based ultrasound contrast agents are special types of ultrasound contrast agents. These contrast agents use perfluorocarbons as the gas filler within the microbubbles, and due to their good stability and biocompatibility, they have been widely used in medical imaging fields.

According to our (Global Info Research) latest study, the global Perfluorocarbon-based Ultrasound Contrast Agents market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Perfluorocarbon-based Ultrasound Contrast Agents market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts by region and country, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (Units), and average selling prices (US$/Unit), 2019-2030
Global Perfluorocarbon-based Ultrasound Contrast Agents market shares of main players, shipments in revenue ($ Million), sales quantity (Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Perfluorocarbon-based Ultrasound Contrast Agents
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Perfluorocarbon-based Ultrasound Contrast Agents market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Bracco, GE Healthcare, Lantheus Medical Imaging, ImaRx Therapeutics, Microvascular Therapeutics, Qi-hui Biopharmaceutical, Feiruida Medical, SUNΛ Med-Engineering, Lizhuo Pharmaceutical, Fuman Group, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Perfluorocarbon-based Ultrasound Contrast Agents market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Sulfur Hexafluoride
Perfluoropropane
Perfluorobutane
Others

Market segment by Application
Liver Ultrasonography
Angiographic Ultrasonography
Cardiac Ultrasonography
Others

Major players covered
Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Perfluorocarbon-based Ultrasound Contrast Agents product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents, with price, sales quantity, revenue, and global market share of Perfluorocarbon-based Ultrasound Contrast Agents from 2019 to 2024.
Chapter 3, the Perfluorocarbon-based Ultrasound Contrast Agents competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Perfluorocarbon-based Ultrasound Contrast Agents breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Perfluorocarbon-based Ultrasound Contrast Agents market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Perfluorocarbon-based Ultrasound Contrast Agents.
Chapter 14 and 15, to describe Perfluorocarbon-based Ultrasound Contrast Agents sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Sulfur Hexafluoride
1.3.3 Perfluoropropane
1.3.4 Perfluorobutane
1.3.5 Others
1.4 Market Analysis by Application
1.4.1 Overview: Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Liver Ultrasonography
1.4.3 Angiographic Ultrasonography
1.4.4 Cardiac Ultrasonography
1.4.5 Others
1.5 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size & Forecast
1.5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (2019-2030)
1.5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price (2019-2030)

2 Manufacturers Profiles
2.1 Bracco
2.1.1 Bracco Details
2.1.2 Bracco Major Business
2.1.3 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.1.4 Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Bracco Recent Developments/Updates
2.2 GE Healthcare
2.2.1 GE Healthcare Details
2.2.2 GE Healthcare Major Business
2.2.3 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.2.4 GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 GE Healthcare Recent Developments/Updates
2.3 Lantheus Medical Imaging
2.3.1 Lantheus Medical Imaging Details
2.3.2 Lantheus Medical Imaging Major Business
2.3.3 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.3.4 Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Lantheus Medical Imaging Recent Developments/Updates
2.4 ImaRx Therapeutics
2.4.1 ImaRx Therapeutics Details
2.4.2 ImaRx Therapeutics Major Business
2.4.3 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.4.4 ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 ImaRx Therapeutics Recent Developments/Updates
2.5 Microvascular Therapeutics
2.5.1 Microvascular Therapeutics Details
2.5.2 Microvascular Therapeutics Major Business
2.5.3 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.5.4 Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Microvascular Therapeutics Recent Developments/Updates
2.6 Qi-hui Biopharmaceutical
2.6.1 Qi-hui Biopharmaceutical Details
2.6.2 Qi-hui Biopharmaceutical Major Business
2.6.3 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.6.4 Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Qi-hui Biopharmaceutical Recent Developments/Updates
2.7 Feiruida Medical
2.7.1 Feiruida Medical Details
2.7.2 Feiruida Medical Major Business
2.7.3 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.7.4 Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Feiruida Medical Recent Developments/Updates
2.8 SUNΛ Med-Engineering
2.8.1 SUNΛ Med-Engineering Details
2.8.2 SUNΛ Med-Engineering Major Business
2.8.3 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.8.4 SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 SUNΛ Med-Engineering Recent Developments/Updates
2.9 Lizhuo Pharmaceutical
2.9.1 Lizhuo Pharmaceutical Details
2.9.2 Lizhuo Pharmaceutical Major Business
2.9.3 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.9.4 Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Lizhuo Pharmaceutical Recent Developments/Updates
2.10 Fuman Group
2.10.1 Fuman Group Details
2.10.2 Fuman Group Major Business
2.10.3 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
2.10.4 Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Fuman Group Recent Developments/Updates

3 Competitive Environment: Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer
3.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Manufacturer (2019-2024)
3.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturer (2019-2024)
3.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Market Share in 2023
3.4.3 Top 6 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer Market Share in 2023
3.5 Perfluorocarbon-based Ultrasound Contrast Agents Market: Overall Company Footprint Analysis
3.5.1 Perfluorocarbon-based Ultrasound Contrast Agents Market: Region Footprint
3.5.2 Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Type Footprint
3.5.3 Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
4.1.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2030)
4.1.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2030)
4.1.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2019-2030)
4.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.4 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.5 South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)
4.6 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030)

5 Market Segment by Type
5.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
5.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2019-2030)
5.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2030)

6 Market Segment by Application
6.1 Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
6.2 Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2019-2030)
6.3 Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2030)

7 North America
7.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
7.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
7.3 North America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
7.3.1 North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
7.3.2 North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
8.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
8.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
8.3 Europe Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
8.3.1 Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
8.3.2 Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
9.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Region
9.3.1 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 South Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
10.1 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
10.2 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
10.3 South America Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
10.3.1 South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
10.3.2 South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
11.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Market Size by Country
11.3.1 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
12.1 Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
12.2 Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
12.3 Perfluorocarbon-based Ultrasound Contrast Agents Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
13.1 Raw Material of Perfluorocarbon-based Ultrasound Contrast Agents and Key Manufacturers
13.2 Manufacturing Costs Percentage of Perfluorocarbon-based Ultrasound Contrast Agents
13.3 Perfluorocarbon-based Ultrasound Contrast Agents Production Process
13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Perfluorocarbon-based Ultrasound Contrast Agents Typical Distributors
14.3 Perfluorocarbon-based Ultrasound Contrast Agents Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Bracco Basic Information, Manufacturing Base and Competitors
Table 4. Bracco Major Business
Table 5. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 6. Bracco Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Bracco Recent Developments/Updates
Table 8. GE Healthcare Basic Information, Manufacturing Base and Competitors
Table 9. GE Healthcare Major Business
Table 10. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 11. GE Healthcare Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. GE Healthcare Recent Developments/Updates
Table 13. Lantheus Medical Imaging Basic Information, Manufacturing Base and Competitors
Table 14. Lantheus Medical Imaging Major Business
Table 15. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 16. Lantheus Medical Imaging Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Lantheus Medical Imaging Recent Developments/Updates
Table 18. ImaRx Therapeutics Basic Information, Manufacturing Base and Competitors
Table 19. ImaRx Therapeutics Major Business
Table 20. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 21. ImaRx Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. ImaRx Therapeutics Recent Developments/Updates
Table 23. Microvascular Therapeutics Basic Information, Manufacturing Base and Competitors
Table 24. Microvascular Therapeutics Major Business
Table 25. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 26. Microvascular Therapeutics Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Microvascular Therapeutics Recent Developments/Updates
Table 28. Qi-hui Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 29. Qi-hui Biopharmaceutical Major Business
Table 30. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 31. Qi-hui Biopharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. Qi-hui Biopharmaceutical Recent Developments/Updates
Table 33. Feiruida Medical Basic Information, Manufacturing Base and Competitors
Table 34. Feiruida Medical Major Business
Table 35. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 36. Feiruida Medical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Feiruida Medical Recent Developments/Updates
Table 38. SUNΛ Med-Engineering Basic Information, Manufacturing Base and Competitors
Table 39. SUNΛ Med-Engineering Major Business
Table 40. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 41. SUNΛ Med-Engineering Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. SUNΛ Med-Engineering Recent Developments/Updates
Table 43. Lizhuo Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 44. Lizhuo Pharmaceutical Major Business
Table 45. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 46. Lizhuo Pharmaceutical Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Lizhuo Pharmaceutical Recent Developments/Updates
Table 48. Fuman Group Basic Information, Manufacturing Base and Competitors
Table 49. Fuman Group Major Business
Table 50. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Product and Services
Table 51. Fuman Group Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. Fuman Group Recent Developments/Updates
Table 53. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Manufacturer (2019-2024) & (Units)
Table 54. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Manufacturer (2019-2024) & (USD Million)
Table 55. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 56. Market Position of Manufacturers in Perfluorocarbon-based Ultrasound Contrast Agents, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 57. Head Office and Perfluorocarbon-based Ultrasound Contrast Agents Production Site of Key Manufacturer
Table 58. Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Type Footprint
Table 59. Perfluorocarbon-based Ultrasound Contrast Agents Market: Company Product Application Footprint
Table 60. Perfluorocarbon-based Ultrasound Contrast Agents New Market Entrants and Barriers to Market Entry
Table 61. Perfluorocarbon-based Ultrasound Contrast Agents Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
Table 63. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2024) & (Units)
Table 64. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2025-2030) & (Units)
Table 65. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 66. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 67. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2019-2024) & (US$/Unit)
Table 68. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Region (2025-2030) & (US$/Unit)
Table 69. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 70. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 71. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2019-2024) & (USD Million)
Table 72. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Type (2025-2030) & (USD Million)
Table 73. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2024) & (US$/Unit)
Table 74. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2025-2030) & (US$/Unit)
Table 75. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 76. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 77. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2024) & (US$/Unit)
Table 80. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2025-2030) & (US$/Unit)
Table 81. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 82. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 83. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 84. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 85. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 86. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 87. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 88. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 89. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 90. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 91. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 92. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 93. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 94. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 95. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 96. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 97. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 98. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 99. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 100. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 101. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2019-2024) & (Units)
Table 102. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Region (2025-2030) & (Units)
Table 103. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2019-2024) & (USD Million)
Table 104. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Region (2025-2030) & (USD Million)
Table 105. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 106. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 107. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 108. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 109. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 110. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 111. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 112. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 113. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2019-2024) & (Units)
Table 114. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Type (2025-2030) & (Units)
Table 115. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2019-2024) & (Units)
Table 116. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Application (2025-2030) & (Units)
Table 117. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2019-2024) & (Units)
Table 118. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity by Country (2025-2030) & (Units)
Table 119. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Perfluorocarbon-based Ultrasound Contrast Agents Raw Material
Table 122. Key Manufacturers of Perfluorocarbon-based Ultrasound Contrast Agents Raw Materials
Table 123. Perfluorocarbon-based Ultrasound Contrast Agents Typical Distributors
Table 124. Perfluorocarbon-based Ultrasound Contrast Agents Typical Customers


List of Figures
Figure 1. Perfluorocarbon-based Ultrasound Contrast Agents Picture
Figure 2. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Type in 2023
Figure 4. Sulfur Hexafluoride Examples
Figure 5. Perfluoropropane Examples
Figure 6. Perfluorobutane Examples
Figure 7. Others Examples
Figure 8. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 9. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application in 2023
Figure 10. Liver Ultrasonography Examples
Figure 11. Angiographic Ultrasonography Examples
Figure 12. Cardiac Ultrasonography Examples
Figure 13. Others Examples
Figure 14. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 15. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 16. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity (2019-2030) & (Units)
Figure 17. Global Perfluorocarbon-based Ultrasound Contrast Agents Price (2019-2030) & (US$/Unit)
Figure 18. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Manufacturer in 2023
Figure 19. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Manufacturer in 2023
Figure 20. Producer Shipments of Perfluorocarbon-based Ultrasound Contrast Agents by Manufacturer Sales ($MM) and Market Share (%): 2023
Figure 21. Top 3 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer (Revenue) Market Share in 2023
Figure 22. Top 6 Perfluorocarbon-based Ultrasound Contrast Agents Manufacturer (Revenue) Market Share in 2023
Figure 23. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Region (2019-2030)
Figure 24. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Region (2019-2030)
Figure 25. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 26. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 27. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 28. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 29. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 30. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 31. Global Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Type (2019-2030)
Figure 32. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Type (2019-2030) & (US$/Unit)
Figure 33. Global Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 34. Global Perfluorocarbon-based Ultrasound Contrast Agents Revenue Market Share by Application (2019-2030)
Figure 35. Global Perfluorocarbon-based Ultrasound Contrast Agents Average Price by Application (2019-2030) & (US$/Unit)
Figure 36. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 37. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 38. North America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 39. North America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 40. United States Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 41. Canada Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 42. Mexico Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 43. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 44. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 45. Europe Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 46. Europe Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 47. Germany Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 48. France Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 49. United Kingdom Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 50. Russia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 51. Italy Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 52. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 53. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 54. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Region (2019-2030)
Figure 55. Asia-Pacific Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Region (2019-2030)
Figure 56. China Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 57. Japan Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 58. South Korea Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 59. India Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 60. Southeast Asia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 61. Australia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 62. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 63. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 64. South America Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 65. South America Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 66. Brazil Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 67. Argentina Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 68. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Type (2019-2030)
Figure 69. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Application (2019-2030)
Figure 70. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Sales Quantity Market Share by Country (2019-2030)
Figure 71. Middle East & Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value Market Share by Country (2019-2030)
Figure 72. Turkey Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 73. Egypt Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 74. Saudi Arabia Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 75. South Africa Perfluorocarbon-based Ultrasound Contrast Agents Consumption Value (2019-2030) & (USD Million)
Figure 76. Perfluorocarbon-based Ultrasound Contrast Agents Market Drivers
Figure 77. Perfluorocarbon-based Ultrasound Contrast Agents Market Restraints
Figure 78. Perfluorocarbon-based Ultrasound Contrast Agents Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Perfluorocarbon-based Ultrasound Contrast Agents in 2023
Figure 81. Manufacturing Process Analysis of Perfluorocarbon-based Ultrasound Contrast Agents
Figure 82. Perfluorocarbon-based Ultrasound Contrast Agents Industrial Chain
Figure 83. Sales Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Bracco
GE Healthcare
Lantheus Medical Imaging
ImaRx Therapeutics
Microvascular Therapeutics
Qi-hui Biopharmaceutical
Feiruida Medical
SUNΛ Med-Engineering
Lizhuo Pharmaceutical
Fuman Group
jiaGou

Add To Cart

gouMai

Buy Now